Usrc North Aiken, Llc is a medicare approved dialysis facility center in Aiken, South Carolina and it has 13 dialysis stations. It is located in Aiken county at 208 University Parkway, Aiken, SC, 29801. You can reach out to the office of Usrc North Aiken, Llc at (803) 642-2670. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. Usrc North Aiken, Llc has the following ownership type - Profit. It was first certified by medicare in May, 2014. The medicare id for this facility is 422646 and it accepts patients under medicare ESRD program.
| Name | Usrc North Aiken, Llc |
|---|---|
| Location | 208 University Parkway, Aiken, South Carolina |
| No. of Dialysis Stations | 13 |
| Medicare ID | 422646 |
| Managed By | Us Renal Care, Inc. |
| Ownership Type | Profit |
| Late Shifts | No |
| 208 University Parkway, Aiken, South Carolina, 29801 | |
| (803) 642-2670 | |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| NPI Number | 1629406384 |
| Organization Name | Us Renal Care North Aiken Dialysis |
| Doing Business As | Usrc North Aiken, Llc |
| Address | 208 University Parkway Aiken, South Carolina, 29801 |
| Phone Number | (803) 642-2670 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 52% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 22% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 26% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 44% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 40% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 14% |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 51% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 27% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 22% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 12% |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 84% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 16% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 65% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 12% |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 59 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 50 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 519 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 60 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 562 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 89 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Usrc North Aiken, Llc with elevated calcium levels.
| Patients with hypercalcemia | 109 |
| Hypercalcemia patient months | 1098 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 116 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 43 |
| Patient months included in arterial venous fistula and catheter summaries | 415 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 97 |
| Hospitalization Rate in facility | 144.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 259.3 |
| Hospitalization Rate: Lower Confidence Limit | 88.2 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Usrc North Aiken, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 46.9 |
| Readmission Rate: Lower Confidence Limit | 16.6 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Usrc North Aiken, Llc get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .33 (As Expected) |
| SIR: Upper Confidence Limit | 1.61 |
| SIR: Lower Confidence Limit | .02 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Usrc North Aiken, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 88 |
| Transfusion Rate in facility | 41.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 86.2 |
| Transfusion Rate: Lower Confidence Limit | 21.6 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Usrc North Aiken, Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 284 |
| Mortality Rate in facility | 12.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.6 |
| Mortality Rate: Lower Confidence Limit | 7.7 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Usrc South Aiken, Llc Location: 169 Crepe Myrtle Dr, Aiken, South Carolina, 29803 Phone: (803) 644-8484 |
Usrc North Aiken, Llc Location: 208 University Parkway, Aiken, South Carolina, 29801 Phone: (803) 642-2670 |
Fresenius Medical Care Aiken Location: 690 Medical Park Dr, Aiken, South Carolina, 29801 Phone: (803) 502-4333 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.
NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
"We found a significant relationship between bacterial infections and acute asthma attacks - above and beyond the expected relationship between viral infections and attacks," says Hans Bisgaard, a professor of paediatrics at the DPAC.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago